1 / 26

“H1N1 by the numbers” Looking at H1N1 outcomes among First Nations using health records

“H1N1 by the numbers” Looking at H1N1 outcomes among First Nations using health records. UBC Learning Circle Drs. Evan Adams & Shannon Waters April 26, 2012. Background. 1 st wave of H1N1 began in spring 2009 & 2 nd wave in fall 2009 BC had a unique, Tripartite response to H1N1

liuz
Download Presentation

“H1N1 by the numbers” Looking at H1N1 outcomes among First Nations using health records

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. “H1N1 by the numbers”Looking at H1N1 outcomes among First Nations using health records UBC Learning Circle Drs. Evan Adams & Shannon Waters April 26, 2012

  2. Background • 1st wave of H1N1 began in spring 2009 & 2nd wave in fall 2009 • BC had a unique, Tripartite response to H1N1 • Tripartite First Nations (FN) H1N1 Working Group with partners from FN Inuit Health Branch, Ministry of Health, Health Authorities, BC Centre for Disease Control & FN Health Council staff • Approaches to help FN deal with H1N1 • Prepositioning of antivirals (Tamiflu) in select FN communities

  3. Objectives of Learning Circle • Methods for evaluating Tripartite Response • quantitative analysis • What can health records tell us about how FN did during H1N1? • What do these things mean? • What recommendations can we have from the evaluation?

  4. Questions for H1N1 Evaluation • Did FN get sicker than other British Columbians? • Did influenza & pneumonia rates vary between FN & other residents across BC? • Did having access to prepositioned Tamiflu reduce the rates of influenza & pneumonia? • Were influenza & pneumonia rates different between those with & without chronic conditions? • Did Tamiflu prescription rates vary between FN & other residents across the province?

  5. Methods: Cohort • Retrospective cohort analysis of BC residents between January 1, 2009 & March 31, 2010 • Study population divided into 6 groups: • Status Indians • Living in Local Health Areas (LHAs) where all FN communities had access to prepositioned Tamiflu (“Prepositioned LHAs”) • Living in LHAs where some FN communities had access to prepositioned Tamiflu (“Mixed LHAs”) • Living in LHAs where no FN communities had access to prepositioned Tamiflu (“Non-Prepositioned LHAs”) This included LHAs that had no FN communities. • Other Residents (OR) • Living in Prepositioned LHAs • Living in Mixed LHAs • Living in Non-Prepositioned LHAs

  6. Methods: Data Sources • Communities with prepositioned Tamiflu were identified from records & communication with FNIHB staff • Geographical location was determined based on postal code within MSP Registration & Premium Billing File & used to assign each individual to their LHA of residence

  7. Methods: Data Sources • MSP Registration & Premium Billing File: identification of cohort, age, gender, geographical location • Status Verification File: Identification of Status Indians as of 2006 • PharmaNet: Tamiflu prescriptions filled in community pharmacies • MSP & Discharge Abstract Database (DAD): ICD-9 & ICD-10 codes used to identify pneumonia & influenza, comorbidities1 & pregnancy 1Using the same ICD-9 & ICD-10 codes used in national chronic disease surveillance. The case definition used was simplified because of data access limitations.

  8. Outcomes of Interest • Physician services & hospitalizations for influenza & pneumonia were outcomes of interest in this study • Rates were age-standardized using the 1991 Canadian population. • ICD-9 & ICD-10 codes were as follows:

  9. Results - Cohort • 49 communities had prepositioned Tamiflu • 6 LHAs were Prepositioned (FN pop = 8,863; 6.1% of total SI pop) • 13 LHAs were Mixed (FN pop = 38,377; 26.2% of total SI pop) • Remaining LHAs were Non-prepositioned (FN pop = 99,234; 67% of total SI pop)

  10. Results – Physician Services Table 1: Age-Standardized rate of MSP services for Influenza & Pneumonia, by cohort, January 1, 2009 – March 31, 2010 *

  11. Results – Physician Services • Prepositioned LHAs: FN had similar levels of physician services for influenza & pneumonia • Mixed LHAs: FN had higher levels of physician services for influenza & pneumonia • Non-prepositioned LHAs: FN had higher levels of physician services for pneumonia

  12. Results – Physician Services • Risk difference for FN physician visits for influenza between Non-prepositioned & Prepositioned LHAs • 70.2 - 37.6 = 32.6 or 46.4% reduction in Prepositioned LHAs • Risk difference for FN physician visits for pneumonia between Non-prepositioned & Prepositioned LHAs • 85.0 - 35.2 = 49.8 or 58.6% reduction in Prepositioned LHAs

  13. Results – Hospitalizations Table 2: Age-standardized hospitalization rate for Influenza & Pneumonia, by cohort, January 1, 2009 - March 31, 2010

  14. Results - Hospitalizations • FN were more likely to be hospitalized for influenza than other BC residents across the province • Only statistically significant in Non-prepositioned LHAs • FN were more likely to be hospitalized for pneumonia than other BC residents across the province • All statistically significant, difference smallest in Prepositioned LHAs

  15. Results – Hospitalizations • Risk difference in FN hospitalization rate for influenza between non-Prepositioned & Prepositioned LHAs • 0.5-0.2 = 0.3 or 60% reduction in Prepositioned LHAs • Risk difference in FN hospitalization rate for pneumonia between non-Prepositioned & Prepositioned LHAs • 11.3-8.8 = 2.5 or 22% reduction in Prepositioned LHAs

  16. Results – Tamiflu Table 3: Age-standardized Prescription Dispensing Rate through PharmaNet, by cohort, January 1, 2009 – March 31, 2010

  17. Results - Tamiflu • FN filled more prescriptions for Tamiflu than other residents across BC • Statistically significant in Mixed and Non-prepositioned LHAs • Risk difference for FN Prescription fill rate between Non-prepositioned and Prepositioned LHAs: • 44.6-24.1 = 20.5 or 46% reduction in prepositioned LHAs • FN with comorbidities were more likely to be prescribed Tamiflu & hospitalized for pneumonia than other residents with comorbidities across BC.

  18. Results - Tamiflu • FN who received Tamiflu were more likely to be hospitalized than those that did not receive Tamiflu (OR=1.7). • Among sick individuals2, how many did or did not receive Tamiflu3 & subsequently become hospitalized4? • Could only be conducted for Non-Prepositioned LHAs as individuals in other LHAs may havehad access to Tamiflu through their prepositioned supplies. • This is contrary to our original hypothesis that individuals who received Tamiflu would be less likely to be hospitalized. 2 Those with an MSP claim for influenza or pneumonia. Multiple visits for influenza & pneumonia were assumed to be the same episode of illness if visits were < 2 weeks apart 3 Individuals were assumed to be taking Tamiflu if they filled a prescription in PharmaNet within ± 3 days of the physician visit 4 Within 2 weeks of their physician visit. If a prescription for Tamiflu was filled in PharmaNet < 10 days before being hospitalized, then the individual was assumed to have been hospitalized while taking Tamiflu

  19. Results – Rate Ratios of Outcomes Table 4: Rate ratios of age-standardized rates between FN & other residents for health outcomes, by LHA type, for the Total BC population, January 1, 2009 – March 31, 2010 • Among Prepositioned LHAs only hospitalizations for pneumonia were statistically higher for FN compared to other residents • In Mixed LHAs, all outcomes were statistically higher among FN except for hospitalizations for influenza • In Non-prepositioned LHAs, all outcomes were statistically higher among FN, except for physician visits for influenza.

  20. Discussion • FN generally had higher age-standardized rates of physician visits & hospitalizations for influenza & pneumonia than other BC residents • In prepositioned LHAs, rates between FN & other residents were not statistically different for physician visits for influenza & pneumonia, hospitalization rate for influenza, or prescription fill rates for Tamiflu • This may be because of lack of access for FN to physician services and to community pharmacies, small numbers, or because fewer individuals got sick

  21. Discussion • Another study5 found that 25% of non-severe outcomes & 20.7% of ICU admissions in 13 Canadian jurisdictions were among Aboriginal people. • Our study found that 10.9% of hospital admissions for influenza & 5.5% of hospitalizations for pneumonia were among FN, suggesting that fewer FN in BC suffered severe outcomes • BC’s definition of ‘FN’ is different from the Aboriginal definition used in other jurisdictions & only 24% of cases in the national study answered the question on Aboriginal status. • This lends some credence to the results of the qualitative H1N1 evaluation, in which many key informants felt that BC FN fared better in terms of fewer severe health outcomes than in other jurisdictions 5Campbell, A. R. (2010). Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ, 182(4), 349-55.

  22. Limitations • Not possible to differentiate H1N1 from other circulating subtypes of influenza • Location of residency depended on postal codes within MSP - these may or may not be accurate • No health care provider service data or Tamiflu dispensing data available from FNIHB nursing stations & thus the outcomes presented here are an underestimate of the effects of H1N1 • FN were identified using a 2006 file, meaning that any new registrants, including children born since 2006 would not have been included as FN in this analysis. • This would minimize the differences between Status Indian & other resident outcomes

  23. Limitations • Prophylactic Tamiflu prescriptions cannot be differentiated from Tamiflu prescribed for actual illness. This would dilute the severity outcome (OR calculations) by including prophylactic cases with actual cases • No death data, however, very few deaths occurred • The case definitions used to identify individuals with comorbidities & pregnant women was not as sophisticated as best-practice standards due to data access limitations

  24. Recommendations • All efforts to increase access to antivirals & support the needs of remote FN communities should continue. • There is some evidence that influenza & pneumonia outcomes were minimized among FN in LHAs with prepositioned Tamiflu • Strategies to minimize the effects of influenza on FN in urban & semi-rural areas should be given additional consideration. • As only 6.1% of FN live in prepositioned LHAs, the greatest potential to reduce disparities from influenza & pneumonia illness will come from additional focus on FN living in urban & semi-rural areas • Health authorities are encouraged to work with FN & FN communities to break down silos of care & address barriers to primary care, tertiary care & community pharmacies

  25. Recommendations • FN community pandemic plans should be updated on a regular basis in partnership with their local Health Authority • A tripartite influenza surveillance strategy that coordinates surveillance information & reduces reporting burden on front-line staff should be developed • All efforts to implement of the Aboriginal Administrative Data Standard should be supported

  26. Questions • Evaluation Questions • Megan Misovic, MMisovic@fnhc.ca • Pandemic Planning Questions • FNIHB, Tess Juliano, Tess.Juliano@hc-sc.gc.ca

More Related